Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine Regimen

Preferred Label : Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine Regimen;

NCIt synonyms : Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine; Cyclophosphamide-Cytarabine-Dexamethasone-Doxorubicin-Thioguanine-Vincristine; Cyclophosphamide-Cytarabine-Dexamethasone-Doxorubicin-Thioguanine-Vincristine Regimen; Doxorubicin/Vincristine/Dexamethasone/Cyclophosphamide/Thioguanine/Cytarabine;

NCIt related terms : CALGB 8811 late intensification;

NCIt definition : A regimen consisting of cyclophosphamide, cytarabine, dexamethasone, doxorubicin, thioguanine and vincristine that may be used in the treatment of acute lymphoblastic leukemia (ALL).;

NCI Metathesaurus CUI : CL1905535;

Codes from synonyms : 47455;

Détails

Origin ID

C192199;

UMLS CUI

C5780985;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Cytarabine Hydrochloride [NCIt concept]
- Dexamethasone [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Thioguanine [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients